Approaching the shared biology of obesity and depression: the stress axis as the locus of gene-environment interactions

被引:204
作者
Bornstein, S. R.
Schuppenies, A.
Wong, M. -L.
Licinio, J.
机构
[1] Univ Dresden, Dept Med, D-01307 Dresden, Germany
[2] Univ Miami, Miller Sch Med, Ctr Pharmacogen, Miami, FL 33152 USA
[3] Univ Miami, Miller Sch Med, Dept Psychiat & Behav Sci, Miami, FL 33152 USA
关键词
depression; obesity; HPA axis;
D O I
10.1038/sj.mp.4001873
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Obesity and depression are serious public health problems and also constitute cardiovascular disease risk factors. Research organizations have called for efforts to explore the interrelationship between obesity and depression. A useful starting point is the fact that in both disorders there is dysregulation of stress systems. We review molecular and clinical evidence indicating that the mediators of the stress response are a key locus for gene environment interactions in the shared biology of depression and obesity. Scientific milestones include translational paradigms such as mice knockouts, imaging and pharmacogenomic approaches that can identify new therapeutic strategies for those burdened by these two afflictions of contemporary civilization. Perspectives for the future are promising. Our ability to dissect the underpinnings of common and complex diseases with shared substrates will be greatly enhanced by the Genes and Environment Initiative, the emerging Large Scale Studies of Genes and Environment in Common Disease, and the UK Biobank Project.
引用
收藏
页码:892 / 902
页数:11
相关论文
共 100 条
  • [1] Drug target discovery by pharmacogenetics: mutations in the melanocortin system and eating disorders
    Adan, RAH
    Vink, T
    [J]. EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2001, 11 (06) : 483 - 490
  • [2] Role of leptin in the neuroendocrine response to fasting
    Ahima, RS
    Prabakaran, D
    Mantzoros, C
    Qu, DQ
    Lowell, B
    MaratosFlier, E
    Flier, JS
    [J]. NATURE, 1996, 382 (6588) : 250 - 252
  • [3] Major depression is associated with significant diurnal elevations in plasma interleukin-6 levels, a shift of its circadian rhythm, and loss of physiological complexity in its secretion: Clinical implications
    Alesci, S
    Martinez, PE
    Kelkar, S
    Ilias, I
    Ronsaville, DS
    Listwak, SJ
    Ayala, AR
    Licinio, J
    Gold, HK
    Kling, MA
    Chrousos, GP
    Gold, PW
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2005, 90 (05) : 2522 - 2530
  • [4] Stereological analysis of the hypothalamic hypocretin/orexin neurons in an animal model of depression
    Allard, JS
    Tizabi, Y
    Shaffery, JP
    Trouth, CO
    Manaye, K
    [J]. NEUROPEPTIDES, 2004, 38 (05) : 311 - 315
  • [5] THE OCRH STIMULATION TEST BEFORE AND AFTER CLINICAL RECOVERY FROM DEPRESSION
    AMSTERDAM, JD
    MAISLIN, G
    WINOKUR, A
    BERWISH, N
    KLING, M
    GOLD, P
    [J]. JOURNAL OF AFFECTIVE DISORDERS, 1988, 14 (03) : 213 - 222
  • [6] The role of corticotropin-releasing factor in depression and anxiety disorders
    Arborelius, L
    Owens, MJ
    Plotsky, PM
    Nemeroff, CB
    [J]. JOURNAL OF ENDOCRINOLOGY, 1999, 160 (01) : 1 - 12
  • [7] Increased corticotropin-releasing hormone immunoreactivity in monoamine-containing pontine nuclei of depressed suicide men
    Austin, MC
    Janosky, JE
    Murphy, HA
    [J]. MOLECULAR PSYCHIATRY, 2003, 8 (03) : 324 - 332
  • [8] Mice deficient for corticotropin-releasing hormone receptor-2 display anxiety-like behaviour and are hypersensitive to stress
    Bale, TL
    Contarino, AB
    Smith, GW
    Chan, R
    Gold, LH
    Sawchenko, PE
    Koob, GF
    Vale, WW
    Lee, KF
    [J]. NATURE GENETICS, 2000, 24 (04) : 410 - 414
  • [9] Inhibitory effect of imipramine on the human corticotropin-releasing-hormone gene promoter activity operates through a PI3-K/AKT mediated pathway
    Basta-Kaim, A
    Budziszewska, B
    Jaworska-Feil, L
    Tetich, M
    Kubera, M
    Leskiewicz, M
    Lason, W
    [J]. NEUROPHARMACOLOGY, 2005, 49 (02) : 156 - 164
  • [10] Polymorphisms in FKBP5 are associated with increased recurrence of depressive episodes and rapid response to antidepressant treatment
    Binder, EB
    Salyakina, D
    Lichtner, P
    Wochnik, GM
    Ising, M
    Pütz, B
    Papiol, S
    Seaman, S
    Lucae, S
    Kohli, MA
    Nickel, T
    Künzel, HE
    Fuchs, B
    Majer, M
    Pfennig, A
    Kern, N
    Brunner, J
    Modell, S
    Baghai, T
    Deiml, T
    Zill, P
    Bondy, B
    Rupprecht, R
    Messer, T
    Köhnlein, O
    Dabitz, H
    Brückl, T
    Müller, N
    Pfister, H
    Lieb, R
    Mueller, JC
    Lohmussaar, E
    Strom, TM
    Bettecken, T
    Meitinger, T
    Uhr, M
    Rein, T
    Holsboer, F
    Muller-Myhsok, B
    [J]. NATURE GENETICS, 2004, 36 (12) : 1319 - 1325